Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
April 15th, 2024 |
Data Coordinating and Operations Center for the ECHO IDeA States Pediatric Clinical Trials Network - 3 (U24 Clinical Trial RequiredInfrastructure) |
National Institutes of Health |
April 15th, 2024 |
Clinical Sites for the Environmental influences on Child Health Outcomes (ECHO) IDeA States Pediatric Clinical Trials Network - 3 (UG1 Clinical Trial Required) |
National Institutes of Health |
November 5th, 2024 |
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) |
National Institutes of Health |
April 24th, 2024 |
Public Health Emergency Preparedness (PHEP) Cooperative Agreement |
Centers for Disease Control ORR |
March 9th, 2026 |
International Research Scientist Development Award (IRSDA) (K01 Independent Clinical Trial Required) |
National Institutes of Health |
April 12th, 2024 |
Denali Commission Program Grants |
Denali Commission |
February 11th, 2027 |
High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional) |
National Institutes of Health |
April 2nd, 2024 |
NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
March 1st, 2024 |
Alumni Engagement Innovation Fund FY24 (Sudan) |
US Mission to Sudan |
May 30th, 2024 |
Research on the Impact of and Methods for Implementing Regional Genomic Medicine eConsult Services (U01 Clinical Trials Optional) |
National Institutes of Health |
May 30th, 2024 |
Solutions to Enable Regional Genomic Medicine eConsult Services (R43/R44 Clinical Trial Optional) |
National Institutes of Health |
May 30th, 2024 |
Solutions to Enable Regional Genomic Medicine eConsult Services (R41/R42 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2027 |
Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional) |
National Institutes of Health |
November 5th, 2026 |
NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required) |
National Institutes of Health |
November 5th, 2026 |
NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
June 10th, 2027 |
NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional) |
National Institutes of Health |
September 1st, 2024 |
Limited Competition: Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed) |
National Institutes of Health |
November 13th, 2026 |
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) |
National Institutes of Health |
January 12th, 2024 |
NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
January 16th, 2024 |
Request for Information-USAID/Burundi Reproductive, Maternal, Newborn, and Child Health, Immunization, and Malaria (RMNCI+M) Activity |
Burundi USAID Bujumbura |
|
November 19th, 2026 |
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
January 24th, 2024 |
Supporting Health Systems Strengthening in Haiti |
Haiti USAID Port Au Prince |
December 28th, 2026 |
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required) |
National Institutes of Health |
March 7th, 2024 |
Collaborative research on influenza and other respiratory pathogens in South Africa |
Centers for Disease Control and Prevention ERA |
December 28th, 2026 |
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
July 13th, 2026 |
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
July 13th, 2026 |
Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required) |
National Institutes of Health |
November 17th, 2026 |
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required) |
National Institutes of Health |
November 13th, 2027 |
Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required) |
National Institutes of Health |
November 17th, 2026 |
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required) |
National Institutes of Health |
April 9th, 2024 |
High-Throughput Screening (HTS) Platform for Discovery of Medications to Treat Alcohol Use Disorder (R43/R44 Clinical Trials Not Allowed) |
National Institutes of Health |
April 9th, 2024 |
High-Throughput Screening (HTS) Platform for Discovery of Medications to Treat Alcohol Use Disorder (R41/R42 Clinical Trials Not Allowed) |
National Institutes of Health |
October 9th, 2025 |
Limited Competition: Revision Applications of Existing NIH Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) Grants (P30 Clinical Trial Not Allowed) |
National Institutes of Health |
August 13th, 2024 |
Chemical Probes and Drugs for Modulating HIV Transcription in the Context of Substance Use Disorders (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
August 13th, 2024 |
Chemical Probes and Drugs for Modulating HIV Transcription in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
January 30th, 2026 |
NIDDK Education Program Grants (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
June 21st, 2024 |
Research Initiative for Vaccine and Antibiotic Allergy (UG3/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
February 6th, 2025 |
NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) |
National Institutes of Health |
February 14th, 2024 |
Geroscience Course (R25 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
February 20th, 2024 |
Service Area Competition-Additional Area |
Health Resources and Services Administration |